A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond

dc.contributor.author	Salgado Fernández, Mercedes
dc.date.accessioned	2017-06-07T06:58:02Z
dc.date.available	2017-06-07T06:58:02Z
dc.date.issued	2014
dc.identifier.issn	0304-3835
dc.identifier.uri	http://hdl.handle.net/20.500.11940/1123
dc.language.iso	eng
dc.title	A critical review of HER2-positive gastric cancer evaluation and treatment: from trastuzumab, and beyond
dc.type	Artigo
dc.authorsophos	Gomez-Martin, C.
dc.authorsophos	Lopez-Rios, F.
dc.authorsophos	Aparicio, J.
dc.authorsophos	Barriuso, J.
dc.authorsophos	Garcia-Carbonero, R.
dc.authorsophos	Pazo, R.
dc.authorsophos	Rivera, F.
dc.authorsophos	Salgado, M.
dc.authorsophos	Salud, A.
dc.authorsophos	Vazquez-Sequeiros, E.
dc.authorsophos	Lordick, F.
dc.identifier.doi	10.1016/j.canlet.2014.05.019
dc.identifier.pmid	24943493
dc.identifier.sophos	17061
dc.issue.number	1
dc.journal.title	CANCER LETTERS
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Ourense - Complexo Hospitalario Universitario de Ourense::Oncoloxía médica
dc.rights.accessRights	openAccess
dc.typesophos	Artículo de Revisión
dc.volume.number	351

Files in this item

Files	Size	Format	View
There are no files associated with this item.